S&P 500   4,267.52
DOW   33,665.02
QQQ   348.82
Stock market today: Global shares trade mixed following technology selloff on Wall Street
New "Mined in America" Lithium Opportunities? (Ad)
10 Best Airline Stocks to Buy
What is a Growth Stock Mutual Fund?
The Real Problem With "Made in America" Lithium (Ad)
Ollie’s Bargain Outlet Goes On Sale 
Will MicroVision Maintain Its Momentum After the Short Squeeze?
The Real Problem With "Made in America" Lithium (Ad)
Apple Partnership Strengthens Unity Software's Investment Appeal
Netflix Collaboration Fuels IAS, DoubleVerify Stock Surge
S&P 500   4,267.52
DOW   33,665.02
QQQ   348.82
Stock market today: Global shares trade mixed following technology selloff on Wall Street
New "Mined in America" Lithium Opportunities? (Ad)
10 Best Airline Stocks to Buy
What is a Growth Stock Mutual Fund?
The Real Problem With "Made in America" Lithium (Ad)
Ollie’s Bargain Outlet Goes On Sale 
Will MicroVision Maintain Its Momentum After the Short Squeeze?
The Real Problem With "Made in America" Lithium (Ad)
Apple Partnership Strengthens Unity Software's Investment Appeal
Netflix Collaboration Fuels IAS, DoubleVerify Stock Surge
S&P 500   4,267.52
DOW   33,665.02
QQQ   348.82
Stock market today: Global shares trade mixed following technology selloff on Wall Street
New "Mined in America" Lithium Opportunities? (Ad)
10 Best Airline Stocks to Buy
What is a Growth Stock Mutual Fund?
The Real Problem With "Made in America" Lithium (Ad)
Ollie’s Bargain Outlet Goes On Sale 
Will MicroVision Maintain Its Momentum After the Short Squeeze?
The Real Problem With "Made in America" Lithium (Ad)
Apple Partnership Strengthens Unity Software's Investment Appeal
Netflix Collaboration Fuels IAS, DoubleVerify Stock Surge
S&P 500   4,267.52
DOW   33,665.02
QQQ   348.82
Stock market today: Global shares trade mixed following technology selloff on Wall Street
New "Mined in America" Lithium Opportunities? (Ad)
10 Best Airline Stocks to Buy
What is a Growth Stock Mutual Fund?
The Real Problem With "Made in America" Lithium (Ad)
Ollie’s Bargain Outlet Goes On Sale 
Will MicroVision Maintain Its Momentum After the Short Squeeze?
The Real Problem With "Made in America" Lithium (Ad)
Apple Partnership Strengthens Unity Software's Investment Appeal
Netflix Collaboration Fuels IAS, DoubleVerify Stock Surge
NASDAQ:AFIB

Acutus Medical (AFIB) Stock Forecast, Price & News

$0.82
+0.02 (+2.50%)
(As of 06/7/2023 ET)
Compare
Today's Range
$0.80
$0.89
50-Day Range
$0.66
$1.02
52-Week Range
$0.48
$2.15
Volume
49,110 shs
Average Volume
153,149 shs
Market Capitalization
$23.79 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.00

Acutus Medical MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
143.7% Upside
$2.00 Price Target
Short Interest
Healthy
2.55% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($2.39) to ($1.51) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.88 out of 5 stars

Medical Sector

650th out of 981 stocks

Surgical & Medical Instruments Industry

62nd out of 99 stocks


AFIB stock logo

About Acutus Medical (NASDAQ:AFIB) Stock

Acutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. The company's product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.

Receive AFIB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Acutus Medical and its competitors with MarketBeat's FREE daily newsletter.

AFIB Stock News Headlines

New "Mined in America" Lithium Opportunities?
The average electric vehicle needs 138 pounds of lithium carbonate for its battery components. But China currently controls the entire lithium supply chain.
Q1 2023 Acutus Medical Inc Earnings Call
Acutus Medical: Q1 Earnings Insights
Acutus Medical (AFIB) to Release Earnings on Thursday
Graphite Shortage Could Derail the $7 Trillion EV Transition
Graphite (not lithium) is expected to see the largest increase in demand of all battery metals over the next decade. But projections warn of an 8 million ton shortfall of graphite by 2040. That's why 97 more graphite mines are needed just to keep up with battery production for the $7 trillion transition to electric vehicles.
Acutus Medical (NASDAQ:AFIB) Trading Up 2.7%
Acutus Medical gives prelim Q1 reports
BTIG Sticks to Its Buy Rating for Acutus Medical (AFIB)
BTIG Sticks to Their Buy Rating for Acutus Medical (AFIB)
Acutus Medical's Earnings: A Preview
See More Headlines

AFIB Price History

AFIB Company Calendar

Last Earnings
3/16/2023
Today
6/07/2023
Next Earnings (Estimated)
8/10/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:AFIB
Employees
291
Year Founded
2011

Price Target and Rating

Average Stock Price Forecast
$2.00
High Stock Price Forecast
$2.50
Low Stock Price Forecast
$1.50
Forecasted Upside/Downside
+143.7%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
2 Analysts

Profitability

Net Income
$-39,620,000.00
Pretax Margin
-93.95%

Debt

Sales & Book Value

Annual Sales
$16.36 million
Book Value
$2.64 per share

Miscellaneous

Free Float
21,935,000
Market Cap
$23.79 million
Optionable
Not Optionable
Beta
0.81

Social Links


Key Executives

  • Mr. R. Scott Huennekens CPA (Age 58)
    M.B.A., Exec. Chairman
    Comp: $121k
  • Mr. David Harrison Roman (Age 40)
    CEO, Pres & Director
    Comp: $679.4k
  • Mr. Vincent J. Burgess (Age 57)
    Consultant
    Comp: $583.5k
  • Mr. Takeo Mukai
    VP of Fin. & Accounting and Interim CFO
  • Dr. Graydon E. Beatty (Age 65)
    Chief Technology Officer
  • Dr. Derrick Chou Ph.D.
    Chief Technology Officer
  • Mr. Tom Sohn (Age 47)
    Sr. VP, Gen. Counsel & Sec.
  • Mr. Shibaji Shome Ph.D.
    VP of Marketing
  • Mr. Charlie Piscitello (Age 59)
    Sr. VP & Chief People Officer
  • Mr. Gary W. Doherty (Age 56)
    Sr. VP of Fin.













AFIB Stock - Frequently Asked Questions

Should I buy or sell Acutus Medical stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Acutus Medical in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" AFIB shares.
View AFIB analyst ratings
or view top-rated stocks.

What is Acutus Medical's stock price forecast for 2023?

2 analysts have issued 12 month price objectives for Acutus Medical's shares. Their AFIB share price forecasts range from $1.50 to $2.50. On average, they expect the company's share price to reach $2.00 in the next year. This suggests a possible upside of 143.7% from the stock's current price.
View analysts price targets for AFIB
or view top-rated stocks among Wall Street analysts.

How have AFIB shares performed in 2023?

Acutus Medical's stock was trading at $1.15 at the beginning of 2023. Since then, AFIB stock has decreased by 28.6% and is now trading at $0.8208.
View the best growth stocks for 2023 here
.

Are investors shorting Acutus Medical?

Acutus Medical saw a increase in short interest in the month of May. As of May 15th, there was short interest totaling 493,200 shares, an increase of 6.3% from the April 30th total of 463,800 shares. Based on an average daily trading volume, of 133,900 shares, the days-to-cover ratio is currently 3.7 days. Approximately 2.6% of the shares of the company are short sold.
View Acutus Medical's Short Interest
.

When is Acutus Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 10th 2023.
View our AFIB earnings forecast
.

How were Acutus Medical's earnings last quarter?

Acutus Medical, Inc. (NASDAQ:AFIB) released its quarterly earnings results on Thursday, March, 16th. The company reported $0.41 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.70) by $1.11. The firm had revenue of $4.96 million for the quarter, compared to analysts' expectations of $4.80 million. Acutus Medical had a negative net margin of 94.43% and a negative trailing twelve-month return on equity of 23.58%.

What guidance has Acutus Medical issued on next quarter's earnings?

Acutus Medical issued an update on its FY 2023 earnings guidance on Friday, May, 12th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $19.00 million-$21.00 million, compared to the consensus revenue estimate of $19.64 million.

What other stocks do shareholders of Acutus Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Acutus Medical investors own include Oak Street Health (OSH), Alibaba Group (BABA), Checkmate Pharmaceuticals (CMPI), Salesforce (CRM), Walt Disney (DIS), DocuSign (DOCU), Marvell Technology (MRVL), NVIDIA (NVDA), Tesla (TSLA) and Twilio (TWLO).

When did Acutus Medical IPO?

(AFIB) raised $126 million in an initial public offering on Thursday, August 6th 2020. The company issued 7,400,000 shares at $16.00-$18.00 per share. J.P. Morgan, BofA Securities and William Blair served as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers.

What is Acutus Medical's stock symbol?

Acutus Medical trades on the NASDAQ under the ticker symbol "AFIB."

Who are Acutus Medical's major shareholders?

Acutus Medical's stock is owned by many different retail and institutional investors. Top institutional shareholders include Renaissance Technologies LLC (1.36%), Schonfeld Strategic Advisors LLC (0.59%), Cerity Partners LLC (0.22%) and Belvedere Trading LLC (0.00%). Insiders that own company stock include James F Hinrichs, Orbimed Advisors Llc and R Scott Huennekens.
View institutional ownership trends
.

How do I buy shares of Acutus Medical?

Shares of AFIB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Acutus Medical's stock price today?

One share of AFIB stock can currently be purchased for approximately $0.82.

How much money does Acutus Medical make?

Acutus Medical (NASDAQ:AFIB) has a market capitalization of $23.79 million and generates $16.36 million in revenue each year. The company earns $-39,620,000.00 in net income (profit) each year or ($0.72) on an earnings per share basis.

How many employees does Acutus Medical have?

The company employs 291 workers across the globe.

Does Acutus Medical have any subsidiaries?
The following companies are subsidiares of Acutus Medical: Acutus Medical N.V..
Read More
How can I contact Acutus Medical?

Acutus Medical's mailing address is 2210 FARADAY AVE SUITE 100, CARLSBAD CA, 92008. The official website for the company is www.acutusmedical.com. The company can be reached via phone at 442-232-6080, via email at investors@acutusmedical.com, or via fax at 442-232-6081.

This page (NASDAQ:AFIB) was last updated on 6/8/2023 by MarketBeat.com Staff

My Account -